Corrections: Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study (The Lancet Infectious Diseases (2017) 17(4) (390–399)(S1473309916305278)(10.1016/S1473-3099(16)30527-8));Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study

The Lancet Infectious Diseases

Volumn 17, Issue 4, 2017, Pages 390-399

  Wang, Yang ^a   Tian, Guo Bao ^b   Zhang, Rong ^c   Shen, Yingbo ^a   Tyrrell, Jonathan M ^d   Huang, Xi ^b   Zhou, Hongwei ^c   Lei, Lei ^a   Li, Hong Yu ^e   Doi, Yohei ^f   Fang, Ying ^c   Ren, Hongwei ^a   Zhong, Lan Lan ^b   Shen, Zhangqi ^a   Zeng, Kun Jiao ^b   Wang, Shaolin ^a   Liu, Jian Hua ^g   Wu, Congming ^a   Walsh, Timothy R ^d   Shen, Jianzhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^e SUN YAT SEN UNIVERSITY   (China)

^f UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^g SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; ERTAPENEM; FOSFOMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; NITROFURANTOIN; PENICILLIN DERIVATIVE; PENICILLINASE; POLYMYXIN B; QUINOLONE DERIVATIVE; TIGECYCLINE;

ACINETOBACTER; ACINETOBACTER INFECTION; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; FEMALE; HOSPITAL ADMISSION; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MAJOR CLINICAL STUDY; MALE; MCR 1 GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NEUTROPENIA; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; ANIMAL; CASE CONTROL STUDY; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; NORMAL HUMAN; PLASMID; PROSPECTIVE STUDY; SEX DIFFERENCE;

ANIMALS; CARBAPENEMS; CASE-CONTROL STUDIES; CHINA; COLISTIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HEALTHY VOLUNTEERS; HUMANS; MOLECULAR EPIDEMIOLOGY; PLASMIDS; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 85010955794     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30103-2     Document Type: Erratum

References (29)

1. 1 The White House Office of the Press Secretary. Obama Administration Releases National Action Plan to Combat Antibiotic-Resistant Bacteria. https://www.whitehouse.gov/the-press-office/2015/03/27/fact-sheet-obama-administration-releases-national-action-plan-combat-ant (accessed May 16, 2016).
2. 2 Walsh, F, Antibiotic resistance: Cameron warns of medical ‘dark ages’. BBC News. http://www.bbc.co.uk/news/health-28098838 (accessed May 16, 2016).
3. 3 WHO. Antimicrobial resistance: global report on surveillance. http://www.who.int/drugresistance/documents/surveillancereport/en/, 2014 (accessed May 16, 2016).
4. 4 McKenna, M, CDC Threat Report: ‘We will soon be in a post-antibiotic era’. http://www.wired.com/2013/09/cdc-amr-rpt1/ (accessed May 16, 2016).
5. 5 Kumarasamy, KK, Toleman, MA, Walsh, TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10 (2010), 597–602.
6. 6 Munoz-Price, LS, Poirel, L, Bonomo, RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13 (2013), 785–796.
7. 7 Evans, BA, Amyes, SG, OXA β-lactamases. Clin Microbiol Rev 27 (2014), 241–263.
8. 8 Giske, CG, Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin. Clin Microbiol Infect 21 (2015), 899–905.
9. 9 Choi, MJ, Ko, KS, Loss of hypermucoviscosity and increased fitness cost in colistin-resistant Klebsiella pneumoniae sequence type 23 strains. Antimicrob Agents Chemother 59 (2015), 6763–6773.
10. 10 Cannatelli, A, Di Pilato, V, Giani, T, et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother 58 (2014), 4399–4403.
11. 11 Bialvaei, AZ, SamadiKafil, H, Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31 (2015), 707–721.
12. 12 Liu, YY, Wang, Y, Walsh, TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16 (2016), 161–168.
13. 13 Yao, X, Doi, Y, Zeng, L, Lv, L, Liu, JH, Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1. Lancet Infect Dis 16 (2016), 288–289.
14. 14 Hasman, H, Hammerum, AM, Hansen, F, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill, 20, 2015, 49.
15. 15 Falgenhauer, L, Waezsada, SE, Yao, Y, et al. Colistin resistance gene mcr-1 in extended-spectrum beta-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect Dis 16 (2016), 282–283.
16. 16 Nordmann, P, Lienhard, R, Kieffer, N, Clerc, O, Poirel, L, Plasmid-mediated colistin-resistant Escherichia coli in bacteremia in Switzerland. Clin Infect Dis 62 (2016), 1322–1323.
17. 17 Garner, JS, Jarvis, WR, Emori, TG, Horan, TC, Hughes, JM, CDC definitions for nosocomial infections. Am J Infect Control 16 (1988), 128–140.
18. 18 Clinical and Laboratory Standards Institute. M100-S25. Performance standards for antimicrobial susceptibility testing. 25th Informational Supplement, 2015, Clinical and Laboratory Standards Institute, Wayne, PA, USA.
19. CTX-M in Escherichia coli from humans and food animals. J Med Microbiol 63 (2014), 835–840.
20. 20 Sáez-López, E, Guiral, E, López, Y, et al. Characterisation of CTX-M-14 and CTX-M-15 producing Escherichia coli strains causing neonatal sepsis. Microb Drug Resist 20 (2014), 281–284.
21. CTX-M-55 gene in an Escherichia coli isolate coproducing 16S rRNA methylase. J Basic Microbiol 53 (2013), 928–933.
22. 22 Toleman, MA, Bugert, JJ, Nizam, SA, Extensively drug-resistant New Delhi metallo-β-lactamase-encoding bacteria in the environment, Dhaka, Bangladesh, 2012. Emerg Infect Dis 6 (2015), 1027–1030.
23. 23 Poirel, L, Savov, E, Nazli, A, et al. Outbreak caused by NDM-1- and RmtB-producing Escherichia coli in Bulgaria. Antimicrob Agents Chemother 58 (2014), 2472–2474.
24. 24 Pors, SE, Olsen, RH, Christensen, JP, Variations in virulence of avian pathogenic Escherichia coli demonstrated by the use of a new in vivo infection model. Vet Microbiol 170 (2014), 368–374.
25. 25 Yu, T, He, T, Yao, H, et al. Prevalence of 16S rRNA methylase gene rmtB among Escherichia coli isolated from bovine mastitis in Ningxia, China. Foodborne Pathog Dis 9 (2015), 770–777.
26. 26 Petty, NK, Ben-Zakour, NL, Stanton-Cook, M, et al. Global dissemination of a multidrug resistant Escherichia coli clone. Proc Natl Acad Sci USA 111 (2014), 5694–5699.
27. 27 Hasman, H, Hammerum, AM, Hansen, F, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill, 20, 2015, 49.
28. 28 Zhao, L, Zhang, J, Zheng, B, et al. Molecular epidemiology and genetic diversity of fluoroquinolone-resistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals. J Clin Microbiol 53 (2015), 766–770.
29. 29 Walsh, TR, Yongning, W, China bans colistin as a feed additive for animals. Lancet Infect Dis 16 (2016), 1102–1103.